Metoclopramide and cellular immune functions during polymicrobial sepsis

European Surgical Research

Volumn 36, Issue 2, 2004, Pages 116-122

  Oberbeck, R ^a   Schmitz, D ^a   Wilsenack, K ^a   Schuler M ^a   Pehle, B ^a   Schedlowski, M ^a   Exton, M S ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cellular immune function; Immune endocrine interaction; Metoclopramide; Polymicrobial sepsis model; Prolactin

Indexed keywords

METOCLOPRAMIDE; PROLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CIRCULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; IMMUNOCOMPETENT CELL; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SEPSIS; SPLEEN CELL;

ANIMALS; APOPTOSIS; CYTOKINES; DOPAMINE ANTAGONISTS; IMMUNITY, CELLULAR; MALE; METOCLOPRAMIDE; MICE; MODELS, ANIMAL; PROLACTIN; SEPSIS; SPLEEN; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 1542723386     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076652     Document Type: Article

References (27)

1. Knöferl MW, Angele MK, Ayala A, Ciaffi WG, Bland KI, Chaudry IH: Insight into the mechanism by which metoclopramide improves immune function after trauma hemorrhage. Am J Physiol 2000;279:C72-C80.
2. Zellweger R, Wichmann MW, Ayala A, Chaudry IH: Metoclopramide: A novel and safe immunomodulating agent for restoring the depressed macrophage immune function after hemorrhage. J Trauma 1998;44:70-77.
3. Brouwers JRBJ, Assies J, Wiesingia WM, Huizing G, Tytgat GN: Plasma prolactin levels after acute and chronic oral administration of domperidone and metoclopramide: A crossover study in healthy volunteers. Clin Endocrinol (Oxf) 1980;12:435-440.
4. Brechot JM, Dupeyron JP, Delattre C, Chastang C, Laaban JP, Rochemaure J: Continuous infusion of high-dose metoclopramide: Comparison of pharmacokinetically adjusted and standard doses for the control of cisplatin-induced acute emesis. Eur J Clin Pharmacol 1991;40:283-286.
5. Jarrar D, Wang P, Song GY, Knöpferl MW, Cioffi WG, Bland KI, Chaudry IH: Metoclopramide: A novel adjunct for improving cardiac and hepatocellular functions after trauma hemorrhage. Am J Physiol 2000;278:E90-E95.
6. Berczi I: Pituitary hormones and immune function. Acta Paediatr 1997;suppl 423:70-75.
7. Reber PM: Prolactin and immunomodulation. Am J Med 1993;95:637-644.
8. Bernton EW, Meltzer MS, Holaday JW: Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 1988;239:401-404.
9. Zellweger R, Wichmann MW, Ayala A, DeMaso CM, Chaudry IH: Prolactin: A novel and safe immunomodulating hormone for the treatment of immunodepression following severe hemorrhage. J Surg Res 1996;63:53-58.
10. Zellweger R, Zhu XH, Wichmann MW, Ayala A, DeMaso CM, Chaudry IH: Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol 1996;157:5748-5754.
11. Zhu XH, Zellweger R, Wichmann MW, Ayala A, Chaudry IH: Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis. Cytokine 1997;9:437-446.
12. Baker CC, Chaudry IH, Gaines HO, Baue AE: Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery 1983;94:331-342.
13. Exton MS, von Hörsten S, Schulte M, Vöge J, Strubel T, Donath S, Nagel E, Westermann J, Schedlowski M: Behaviourally conditioned immunosuppression using cyclosporine A. J Neuroimmunol 1998;88:182-191.
14. Besedovsky H, del Ray A: Immune-neuroendocrine interactions: Facts and hypothesis. Endocr Rev 1996;17:69-102.
15. Waydhas C, Nast-Kolb D, Jochum M, Trupka A, Lenk S, Fritz H, Schweiberer L: Inflammatory mediators, infection, sepsis and multiple organ failure after severe trauma. Arch Surg 1992;127:460-467.
16. Cohen JJ: Apoptosis. Immunol Today 1993;14:126-130.
17. Hess KL, Tudor KRS, Johnson JD, Askew DS, Cook-Mills JM: Human and murine high endothelial venule cells phagocytose apoptotic leukocytes. Exp Cell Res 1997;236:4004-4011.
18. Fadok VA, Laszlo DJ, Noble PW, Weinstein L, Riches DWH, Hensin PM: Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells. J Immunol 1993;151:4274-4283.
19. Keel M, Ungethüm U, Steckholzer U, Niederer E, Hartung T, Trentz O, Ertel W: Interleukin-10 counterregulates proinflammatory cytokine-induced neutrophil apoptosis during severe sepsis. Blood 1997;90:3356-3363.
20. Feterowski C, Weighardt H, Emmanuilidis K, Hartung T, Holzmann B: Immune protection against septic peritonitis in endotoxin-primed mice is related to reduced neutrophil apoptosis. Eur J Immunol 2001;3:1268-1277.
21. Buckley AR, Buckley DJ: Prolactin regulation of apoptosis-associated gene expression in T-cells. Ann NY Acad Sci 2000;917:522-533.
22. Basu S, Dasgupta PS: Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 2000;102:113-124.
23. Rook GAW, Hernandez-Pando R, Lightman SL: Hormones, peripherally activated prohormones and regulation of the Th1/Th2 imbalance. Immunol Today 1994;15:301-323.
24. Wong GC, Clark SC: Multiple actions of interleukin-6 within a cytokine network. Immunol Today 1988;9:137-139.
25. Oberbeck R, Dahlweid M, Koch R, Emmendörfer A, Pape HC: Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis. Crit Care Med 2001;29:380-384.
26. Oberbeck R, Nickel E, von Griensven M, Tschernig T, Wittwer T, Schmitz D, Pape HC: Influence of β-adrenoceptor antagonists on hemorrhage-induced cellular immune suppression. Shock 2002;28:963-968.
27. 2-adrenergic mechanism. J Immunol 1996;156:93-99.